Three steps to cancer: how phosphorylation of tubulin, tubulin tyrosine ligase and P-glycoprotein may generate and sustain cancer Haitham T. Idriss Review 29 April 2004 Pages: 101 - 104
Population pharmacokinetics of cisplatin in adult cancer patients Felix E. de JonghJames M. GalloAlex Sparreboom Original Article 30 April 2004 Pages: 105 - 112
In vitro assessment of nucleoside analogs in multiple myeloma Nancy L. KrettMary AyresVarsha Gandhi Original Article 04 May 2004 Pages: 113 - 121
Induction of spermidine/spermine N 1-acetyltransferase in breast cancer tissues treated with the polyamine analogue N 1,N 11-diethylnorspermine Edward GabrielsonEllen TullyRobert A. Casero Jr Original Article 08 May 2004 Pages: 122 - 126
Plasma and cerebrospinal fluid pharmacokinetics of rebeccamycin (NSC 655649) in nonhuman primates Stacey L. BergAlexander AleksicSusan M. Blaney Original Article 18 May 2004 Pages: 127 - 130
In vivo imaging of hepatobiliary transport function mediated by multidrug resistance associated protein and P-glycoprotein N. Harry HendrikseFolkert KuipersElisabeth G. E. de Vries Original Article 30 April 2004 Pages: 131 - 138
Synergistic cytotoxicity of the ribonucleotide reductase inhibitor didox (3,4-dihydroxy-benzohydroxamic acid) and the alkylating agent carmustine (BCNU) in 9L rat gliosarcoma cells and DAOY human medulloblastoma cells Zsuzsanna HorvathThomas HöchtlTarik Tihan Original Article 04 May 2004 Pages: 139 - 145
Late-onset delayed excretion of methotrexate Jennifer L. PauleyJohn Carl PanettaChing-Hon Pui Original Article 18 May 2004 Pages: 146 - 152
Effect of cyclosporine A on the tissue distribution and pharmacokinetics of etoposide Jaime Cárcel-TrullolsFrancisca Torres-MolinaJosé Esteban Peris Original article 27 April 2004 Pages: 153 - 160
Atypical protein-kinase Cζ, but neither conventional Ca2+-dependent protein-kinase C isoenzymes nor Ca2+-calmodulin, participates in regulation of telomerase activity in Burkitt’s lymphoma cells Rumiana BakalovaHideki OhbaYoshinobu Baba Original Article 23 April 2004 Pages: 161 - 172
Phase II study of weekly docetaxel combined with cisplatin in patients with advanced non-small-cell lung cancer Toshiyuki TsunodaTomonobu KoizumiKeishi Kubo Original Article 04 May 2004 Pages: 173 - 177
Phase I/II trial of topotecan given as continuous infusion in combination with oxaliplatin in 5-FU-pretreated patients with colorectal cancer G. HütterH. SzélenyiE. Thiel Original Article 28 April 2004 Pages: 178 - 184
Receptor occupancy theory-based analysis of antiemetic effects and standard doses of 5-HT3 receptor antagonists in cancer patients Yasuhiko YamadaMunetoshi SugiuraTatsuji Iga Original Article 27 May 2004 Pages: 185 - 190
Tumor lysis syndrome following docetaxel therapy for extensive metastatic prostate cancer Steven M. Sorscher Short Communication 18 May 2004 Pages: 191 - 192
